name: | Phenformin |
ATC code: | A10BA01 | route: | oral |
n-compartments | 1 |
Phenformin is a biguanide class oral antihyperglycemic agent that was previously used for the management of type 2 diabetes mellitus. Due to a high risk of lactic acidosis, phenformin has been withdrawn from the market in most countries and is no longer approved for clinical use.
Pharmacokinetic parameters reported for healthy adults following oral administration.
Scheen, AJ (1996). Clinical pharmacokinetics of metformin. Clinical pharmacokinetics 30(5) 359–371. DOI:10.2165/00003088-199630050-00003 PUBMED:https://pubmed.ncbi.nlm.nih.gov/8743335
Scheen, AJ, & Lefèbvre, PJ (1995). Antihyperglycaemic agents. Drug interactions of clinical importance. Drug safety 12(1) 32–45. DOI:10.2165/00002018-199512010-00003 PUBMED:https://pubmed.ncbi.nlm.nih.gov/7741982
Marchetti, P, et al., & Navalesi, R (1991). Pharmacokinetic optimisation of oral hypoglycaemic therapy. Clinical pharmacokinetics 21(4) 308–317. DOI:10.2165/00003088-199121040-00006 PUBMED:https://pubmed.ncbi.nlm.nih.gov/1760902